Related Experiment Video
Updated: Jun 27, 2026

Revealing the Ferroptotic Phenotype of Medulloblastoma
Published on: March 15, 2024
Monocyte-Derived Macrophage Ferroptosis Amplifies Cholangitis in Primary Biliary Cholangitis via a Calpain/ACSL4 Axis
Tianfu Liu1, Yichen Huang2, Yizhe Wang3
1Department of Hepatology, The Second Hospital & Clinical Medical School, Lanzhou University, Lanzhou 730030, China.
Abstract:
Background: Recruitment and activation of monocyte-derived macrophages (MoMFs) sustain cholangitis in primary biliary cholangitis (PBC), but whether MoMFs amplify inflammation through ferroptosis remains unclear. We defined ferroptotic programs in MoMFs and evaluated the calpain/ACSL4 axis as a regulatory and therapeutic node. Methods: We analysed a public human liver single-cell RNA sequencing (scRNA-seq) dataset and examined MoMF-associated ACSL4 and 4-hydroxynonenal (4-HNE) signals in CD11b+CD68+ cells by multiplex immunofluorescence. We used a 2OA-BSA-induced PBC-like mouse model to assess liver injury, inflammation and ferroptosis-related markers and tested Liproxstatin-1 (Lip-1), rosiglitazone (ROSI) or the calpain inhibitor PD150606. Bone marrow-derived macrophages (BMDMs) from control and PBC mice were profiled and challenged with RSL3, with or without Ferrostatin-1 (Fer-1), ROSI or PD150606. Results: MoMFs were expanded in PBC livers and showed the strongest induction of ferroptosis signatures, centered on ACSL4, with enhanced inflammatory crosstalk with cholangiocytes. Human PBC tissues showed increased CD11b+CD68+ cells positive for ACSL4 or 4-HNE. In PBC-like mice, malondialdehyde (MDA) increased and glutathione (GSH) decreased, and macrophages showed greater colocalization with ferroptosis markers; Lip-1, ROSI or PD150606 improved liver biochemistry, reduced inflammation scores and limited macrophage infiltration. PBC-derived BMDMs upregulated ACSL4 and CAPN1/2 and were more sensitive to RSL3; Fer-1, ROSI or PD150606 attenuated ferroptosis-associated molecular changes. Conclusions: MoMF ferroptosis is prominently engaged in PBC, and our findings implicate a pharmacologically tractable calpain/ACSL4 axis that may contribute to macrophage ferroptotic susceptibility and inflammatory liver injury.
Insights
Monocyte-derived macrophages (MoMFs) drive inflammation in primary biliary cholangitis (PBC) through ferroptosis. Targeting the calpain/ACSL4 axis offers a potential therapeutic strategy for this liver disease.
Area of Science:
- Immunology
- Cell Biology
- Hepatology
Background:
- Monocyte-derived macrophages (MoMFs) are key drivers of inflammation in primary biliary cholangitis (PBC).
- The role of MoMF ferroptosis in amplifying PBC-associated cholangitis was previously unclear.
- The calpain/ACSL4 axis was investigated as a potential regulator of MoMF ferroptosis.
Purpose of the Study:
- To define ferroptotic programs in MoMFs within the context of PBC.
- To evaluate the calpain/ACSL4 axis as a regulatory and therapeutic target in PBC.
- To investigate the crosstalk between MoMFs and cholangiocytes in PBC pathogenesis.
Main Methods:
- Analysis of human liver single-cell RNA sequencing data to identify MoMF ferroptosis signatures.
- Multiplex immunofluorescence to detect ACSL4 and 4-hydroxynonenal (4-HNE) in human PBC tissues.
- Utilized a 2OA-BSA-induced mouse model of PBC to assess liver injury, inflammation, and ferroptosis markers.
- Pharmacological intervention with Liproxstatin-1 (Lip-1), rosiglitazone (ROSI), or PD150606 in mouse models and bone marrow-derived macrophages (BMDMs).
Main Results:
- MoMFs were expanded in PBC livers, exhibiting strong ferroptosis signatures centered on ACSL4 and increased inflammatory crosstalk with cholangiocytes.
- Human PBC tissues showed elevated ACSL4 and 4-HNE expression in CD11b+CD68+ cells.
- PBC-like mice displayed increased oxidative stress (MDA, decreased GSH) and macrophage infiltration associated with ferroptosis markers.
- Treatments with Lip-1, ROSI, or PD150606 ameliorated liver injury, reduced inflammation, and limited macrophage infiltration in PBC models.
- PBC-derived BMDMs showed upregulated ACSL4 and CAPN1/2, increased sensitivity to ferroptosis inducers, and attenuated ferroptosis upon treatment with Ferrostatin-1 (Fer-1), ROSI, or PD150606.
Conclusions:
- MoMF ferroptosis is a significant factor in the pathogenesis of primary biliary cholangitis.
- The calpain/ACSL4 axis represents a pharmacologically tractable target that influences MoMF ferroptotic susceptibility.
- Targeting this axis holds promise for mitigating macrophage-driven inflammatory liver injury in PBC.
Related Concept Videos
Chronic Pancreatitis II: Pathophysiology
Necrosis
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become anucleated and die, but their...
Chronic Pancreatitis I: Introduction
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
Cirrhosis II: Pathophysiology
Acute Pancreatitis II: Pathophysiology
Cholecystitis